PhaseBio Pharmaceuticals Inc. (PHAS) fell -12.5% or -1.5 to $10.5. It is nearly 241796 shares traded, which is 59.92% compare to the average total volume 403527. The market cap of PHAS is $257.23 million. The year to date change is 270.28%. The 52 week price range is from $2.55 to $13.4. Price of PHAS have changed 42.52% during last week. N/A N/A 140.00% over last 6 months and 140.00% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PHAS is 4.39. It is -58.19% below current price. The 52-week High is 13.4. It is 27.62% from the current price. The 52-week Low is 2.55. It is -75.71% from current price.
There are some statistics of PHAS. It is has market cap $257.23 million. The share outstanding is 24.50 million. The average volume is 403527. The percent of top 15 Institution holding is 31.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is 112.68%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -62.32%.